Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic Carcinoma.
Mikami E, Nakamichi S, Nagano A, Misawa K, Hayashi A, Tozuka T, Takano N, Noro R, Maebayashi K, Kubokura H, Terasaki Y, Kubota K, Seike M. Mikami E, et al. Among authors: noro r. Intern Med. 2023 Sep 15;62(18):2731-2735. doi: 10.2169/internalmedicine.1142-22. Epub 2023 Jan 15. Intern Med. 2023. PMID: 36642523 Free PMC article.
Pulmonary manifestation of inflammatory bowel disease: Two case reports.
Suzuki A, Noro R, Omori J, Terasaki Y, Tanaka T, Fujita K, Takano N, Sakurai Y, Suga M, Hayashi A, Okamura K, Saito Y, Kasahara K, Iwakiri K, Kubota K, Seike M. Suzuki A, et al. Among authors: noro r. Respir Med Case Rep. 2023 Aug 22;45:101914. doi: 10.1016/j.rmcr.2023.101914. eCollection 2023. Respir Med Case Rep. 2023. PMID: 37719886 Free PMC article.
Clinicopathological Characteristics of Everolimus-Associated Interstitial Lung Disease: A Single-Center Consecutive Analysis.
Saito Y, Terasaki Y, Kashiwada T, Tanaka T, Takei H, Kimura G, Kondo Y, Kawagoe T, Matsushita A, Noro R, Minegishi Y, Kamio K, Seike M, Gemma A. Saito Y, et al. Among authors: noro r. J Nippon Med Sch. 2024 May 21;91(2):207-217. doi: 10.1272/jnms.JNMS.2024_91-211. Epub 2024 Jan 16. J Nippon Med Sch. 2024. PMID: 38233124 Free article.
Combination chemotherapy of alternating etoposide and carboplatin with weekly administration of irinotecan and cisplatin in extensive-stage small-cell lung cancer.
Yoshimura A, Noro R, Miyanaga A, Mizutani H, Kosaihira S, Minegishi Y, Seike M, Hino M, Ando M, Nomura K, Okano T, Kobayashi K, Gemma A; East Japan Chesters Group. Yoshimura A, et al. Among authors: noro r. Anticancer Res. 2012 Oct;32(10):4473-8. Anticancer Res. 2012. PMID: 23060575 Clinical Trial.
Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion.
Kitamura K, Kubota K, Ando M, Takahashi S, Nishijima N, Sugano T, Toyokawa M, Miwa K, Kosaihira S, Noro R, Minegishi Y, Seike M, Yoshimura A, Gemma A. Kitamura K, et al. Among authors: noro r. Cancer Chemother Pharmacol. 2013 Feb;71(2):457-61. doi: 10.1007/s00280-012-2026-4. Epub 2012 Nov 21. Cancer Chemother Pharmacol. 2013. PMID: 23178954
Alternating chemotherapy with amrubicin plus cisplatin and weekly administration of irinotecan plus cisplatin for extensive-stage small cell lung cancer.
Noro R, Yoshimura A, Yamamoto K, Miyanaga A, Mizutani H, Minegishi Y, Seike M, Kubota K, Kosaihira S, Hino M, Ando M, Nomura K, Okano T, Kobayashi K, Uematsu K, Gemma A; East Japan Chesters Group. Noro R, et al. Anticancer Res. 2013 Mar;33(3):1117-23. Anticancer Res. 2013. PMID: 23482789 Clinical Trial.
94 results